Evaluation of (-)-[18 F]Flubatine-specific binding: Implications for reference region approaches

Synapse. 2018 Mar;72(3):10.1002/syn.22016. doi: 10.1002/syn.22016. Epub 2017 Nov 17.

Abstract

We aimed to characterize changes in binding of (-)-[18 F]Flubatine to α4 β2 *-nicotinic acetylcholine receptors (α4 β2 *-nAChRs) during a tobacco cigarette smoking challenge. Displacement of (-)-[18 F]Flubatine throughout the brain was quantified as change in (-)-[18 F]Flubatine distribution volume (VT ), with particular emphasis on regions with low VT . Three tobacco smokers were imaged with positron emission tomography (PET) during a 210 min bolus-plus-constant infusion of (-)-[18 F]Flubatine. A tobacco cigarette was smoked in the PET scanner ∼125 min after the start of (-)-[18 F]Flubatine injection. Equilibrium analysis was used to estimate VT at baseline (90-120 min) and after cigarette challenge (180-210 min), at the time of greatest receptor occupancy by nicotine. Smoking reduced VT by 21 ± 9% (average ±SD) in corpus callosum, 17 ± 9% in frontal cortex, 36 ± 11% in cerebellum, and 22 ± 10% in putamen. The finding of displaceable (-)-[18 F]Flubatine binding throughout the brain is an important consideration for reference region-based quantification approaches with this tracer. We observed displacement of (-)-[18 F]Flubatine binding to α4 β2 *-nicotinic acetylcholine receptors in corpus callosum by a tobacco cigarette challenge. We conclude that reference region approaches utilizing corpus callosum should first perform careful characterization of displaceable (-)-[18 F]Flubatine binding and nondisplaceable kinetics in this putative reference region.

Keywords: positron emission tomography; reference region; tobacco smoking; white matter; α4β2*-nicotinic acetylcholine receptors.

Publication types

  • Evaluation Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Benzamides* / pharmacokinetics
  • Brain / diagnostic imaging*
  • Brain / drug effects
  • Brain / metabolism*
  • Brain Mapping
  • Bridged Bicyclo Compounds, Heterocyclic* / pharmacokinetics
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nicotine / administration & dosage
  • Nicotine / pharmacokinetics
  • Nicotinic Agonists / administration & dosage
  • Nicotinic Agonists / pharmacokinetics
  • Positron-Emission Tomography*
  • Protein Binding
  • Radiopharmaceuticals* / pharmacokinetics
  • Receptors, Nicotinic / metabolism*
  • Smoking / metabolism

Substances

  • Benzamides
  • Bridged Bicyclo Compounds, Heterocyclic
  • Nicotinic Agonists
  • Radiopharmaceuticals
  • Receptors, Nicotinic
  • fluoronorchloroepibatidine
  • nicotinic receptor alpha4beta2
  • Nicotine